Genetics of dystonia

Seminars in Neurology

Volumn 31, Issue 5, 2011, Pages 441-448

  Fuchs, Tania ^a   Ozelius, Laurie J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

dystonia genes; dystonia plus; paroxysmal dystonia; Primary torsion dystonia

Indexed keywords

MYOFRIBILLOGENESIS REGULATOR 1; PROSTATE APOPTOSIS RESPONSE 4; PROTEIN KINASE INTERFERON INDUCIBLE DOUBLE STRANDED RNA DEPENDENT ACTIVATOR; THANATOS ASSOCIATED PROTEIN DOMAIN CONTAINING APOPTOSIS ASSOCIATED PROTEIN 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AUTOSOMAL RECESSIVE DISORDER; BODY POSTURE; DISEASE SEVERITY; DNA BINDING; DOPAMINE RESPONSIVE DYSTONIA; DYSKINESIA; DYSTONIA; DYT1 DYSTONIA; DYT1 GENE; DYT10 GENE; DYT13 GENE; DYT15 GENE; DYT16 GENE; DYT17 GENE; DYT18 GENE; DYT19 GENE; DYT2 GENE; DYT20 GENE; DYT21; DYT3 GENE; DYT4 GENE; DYT5 GENE; DYT6 GENE; DYT7 GENE; DYT9 GENE; FOCAL DYSTONIA; GENE; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MISSENSE MUTATION; MUSCLE CONTRACTION; MYOCLONUS; MYOCLONUS DYSTONIA; NUCLEAR LOCALIZATION SIGNAL; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PARKINSONISM; PAROXYSMAL DYSTONIA; PAROXYSMAL EXERCISE INDUCED DYSKINESIA; PAROXYSMAL NON KINESIGENIC DYSKINESIA; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TOR1A GENE; TORSION DYSTONIA;

CHOREA; DYSTONIA; DYSTONIC DISORDERS; HUMANS; MUTATION; MYOCLONUS; PARKINSONIAN DISORDERS; PHENOTYPE;

EID: 84856200631     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0031-1299783     Document Type: Review

References (91)

1. Nutt J G., Muenter M D., Aronson A, Kurland L T., Melton L J. III. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 1988 3 3 188-194
2. Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group. A prevalence study of primary dystonia in eight European countries. J Neurol 2000 247 10 787-792
3. Risch N, de Leon D, Ozelius L et al. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat Genet 1995 9 2 152-159
4. Ozelius L J., Hewett J W., Page C E. et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997 17 1 40-48 (Pubitemid 27377530)
5. Ozelius L J., Bressman S B. Genetic and clinical features of primary torsion dystonia. Neurobiol Dis 2011 42 2 127-135
6. Zirn B, Grundmann K, Huppke P et al. Novel TOR1A mutation p.Arg288Gln in early-onset dystonia (DYT1). J Neurol Neurosurg Psychiatry 2008 79 12 1327-1330
7. Calakos N, Patel V D., Gottron M et al. Functional evidence implicating a novel TOR1A mutation in idiopathic, late-onset focal dystonia. J Med Genet 2010 47 9 646-650
8. Schmidt A, Klein C. The role of genes in causing dystonia. Eur J Neurol 2010 17 Suppl 1 65-70
9. Edwards M J., Huang Y Z., Wood N W., Rothwell J C., Bhatia K P. Different patterns of electrophysiological deficits in manifesting and non-manifesting carriers of the DYT1 gene mutation. Brain 2003 126 Pt 9 2074-2080 (Pubitemid 37059447)
10. Saunders-Pullman R, Shriberg J, Shanker V, Bressman S B. Penetrance and expression of dystonia genes. Adv Neurol 2004 94 121-125
11. Kock N, Naismith T V., Boston H E. et al. Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier. Hum Mol Genet 2006 15 8 1355-1364
12. Risch N J., Bressman S B., Senthil G, Ozelius L J. Intragenic Cis and Trans modification of genetic susceptibility in DYT1 torsion dystonia. Am J Hum Genet 2007 80 6 1188-1193 (Pubitemid 47579354)
13. Kamm C, Fischer H, Garavaglia B et al. Susceptibility to DYT1 dystonia in European patients is modified by the D216H polymorphism. Neurology 2008 70 23 2261-2262
14. Granata A, Warner T T. The role of torsinA in dystonia. Eur J Neurol 2010 17 Suppl 1 81-87
15. Warner T T., Granata A, Schiavo G. TorsinA and DYT1 dystonia: a synaptopathy? Biochem Soc Trans 2010 38 2 452-456
16. Tanabe L M., Kim C E., Alagem N, Dauer W T. Primary dystonia: molecules and mechanisms. Nat Rev Neurol 2009 5 11 598-609
17. Bragg D C., Armata I A., Nery F C., Breakefield X O., Sharma N. Molecular pathways in dystonia. Neurobiol Dis 2011 42 2 136-147
18. Ozelius L J., Lubarr N, Bressman S B. Milestones in dystonia. Mov Disord 2011 26 6 1106-1126
19. Wilcox R A., Winkler S, Lohmann K, Klein C. Whispering dysphonia in an Australian family (DYT4): A clinical and genetic reappraisal. Mov Disord 2011 In press
20. Fuchs T, Gavarini S, Saunders-Pullman R et al. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet 2009 41 3 286-288
21. Bonetti M, Barzaghi C, Brancati F et al. Mutation screening of the DYT6/THAP1 gene in Italy. Mov Disord 2009 24 16 2424-2427
22. Djarmati A, Schneider S A., Lohmann K et al. Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study. Lancet Neurol 2009 8 5 447-452
23. Bressman S B., Raymond D, Fuchs T, Heiman G A., Ozelius L J., Saunders-Pullman R. Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study. Lancet Neurol 2009 8 5 441-446
24. Paisán-Ruiz C, Ruiz-Martinez J, Ruibal M et al. Identification of a novel THAP1 mutation at R29 amino-acid residue in sporadic patients with early-onset dystonia. Mov Disord 2009 24 16 2428-2429
25. Clot F, Grabli D, Burbaud P et al. Screening of the THAP1 gene in patients with early-onset dystonia: myoclonic jerks are part of the dystonia 6 phenotype. Neurogenetics 2011 12 1 87-89
26. Groen J L., Ritz K, Contarino M F. et al. DYT6 dystonia: mutation screening, phenotype, and response to deep brain stimulation. Mov Disord 2010 25 14 2420-2427
27. Houlden H, Schneider S A., Paudel R et al. THAP1 mutations (DYT6) are an additional cause of early-onset dystonia. Neurology 2010 74 10 846-850
28. Söhn A S., Glöckle N, Doetzer A D. et al. Prevalence of THAP1 sequence variants in German patients with primary dystonia. Mov Disord 2010 25 12 1982-1986
29. Zittel S, Moll C K., Brüggemann N et al. Clinical neuroimaging and electrophysiological assessment of three DYT6 dystonia families. Mov Disord 2010 25 14 2405-2412
30. Xiao J, Zhao Y, Bastian R W. et al. Novel THAP1 sequence variants in primary dystonia. Neurology 2010 74 3 229-238
31. Groen J L., Yildirim E, Ritz K et al. THAP1 mutations are infrequent in spasmodic dysphonia. Mov Disord 2011 Apr 29
32. Blanchard A, Roubertie A, Simonetta-Moreau M et al. Singular DYT6 phenotypes in association with new THAP1 frameshift mutations. Mov Disord 2011 26 9 1775-1777
33. Jech R, Bare M, Kepelová A, Urgok D, Havránková P, Rika E. DYT 6a novel THAP1 mutation with excellent effect on pallidal DBS. Mov Disord 2011 26 5 924-925
34. Schneider S A., Ramirez A, Shafiee K et al. Homozygous THAP1 mutations as cause of early-onset generalized dystonia. Mov Disord 2011 26 5 858-861
35. Cheng F B., Wan X H., Feng J C., Wang L, Yang Y M., Cui L Y. Clinical and genetic evaluation of DYT1 and DYT6 primary dystonia in China. Eur J Neurol 2011 18 3 497-503
36. De Carvalho Aguiar P, Fuchs T, Borges V et al. Screening of Brazilian families with primary dystonia reveals a novel THAP1 mutation and a de novo TOR1A GAG deletion. Mov Disord 2010 25 16 2854-2857
37. Gavarini S, Cayrol C, Fuchs T et al. Direct interaction between causative genes of DYT1 and DYT6 primary dystonia. Ann Neurol 2010 68 4 549-553
38. Clouaire T, Roussigne M, Ecochard V, Mathe C, Amalric F, Girard J P. The THAP domain of THAP1 is a large C2CH module with zinc-dependent sequence-specific DNA-binding activity. Proc Natl Acad Sci U S A 2005 102 19 6907-6912 (Pubitemid 40675415)
39. Roussigne M, Cayrol C, Clouaire T, Amalric F, Girard J P. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies. Oncogene 2003 22 16 2432-2442 (Pubitemid 36564817)
40. Cayrol C, Lacroix C, Mathe C et al. The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes. Blood 2007 109 2 584-594 (Pubitemid 46115969)
41. Duan W, Zhang Z, Gash D M., Mattson M P. Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease. Ann Neurol 1999 46 4 587-597 (Pubitemid 29466437)
42. Kaiser F J., Osmanoric A, Rakovic A et al. The dystonia gene DYT1 is repressed by the transcription factor THAP1 (DYT6). Ann Neurol 2010 68 4 554-559
43. Valente E M., Bentivoglio A R., Cassetta E et al. DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.1336.32 in an Italian family with cranial-cervical or upper limb onset. Ann Neurol 2001 49 3 362-366 (Pubitemid 32202790)
44. Chouery E, Kfoury J, Delague V et al. A novel locus for autosomal recessive primary torsion dystonia (DYT17) maps to 20p11.22-q13.12. Neurogenetics 2008 9 4 287-293
45. Defazio G, Berardelli A, Hallett M. Do primary adult-onset focal dystonias share aetiological factors? Brain 2007 130 Pt 5 1183-1193 (Pubitemid 47355939)
46. Waddy H M., Fletcher N A., Harding A E., Marsden C D. A genetic study of idiopathic focal dystonias. Ann Neurol 1991 29 3 320-324
47. Leube B, Rudnicki D, Ratzlaff T, Kessler K R., Benecke R, Auburger G. Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution. Hum Mol Genet 1996 5 10 1673-1677 (Pubitemid 26328888)
48. Norgren N, Mattson E, Forsgren L, Holmberg M. A high-penetrance form of late-onset torsion dystonia maps to a novel locus (DYT21) on chromosome 2q14.3-q21.3. Neurogenetics 2011 12 2 137-143
49. Jarman P R., del Grosso N, Valente E M. et al. Primary torsion dystonia: the search for genes is not over. J Neurol Neurosurg Psychiatry 1999 67 3 395-397 (Pubitemid 29392604)
50. Müller U. The monogenic primary dystonias. Brain 2009 132 Pt 8 2005-2025
51. Lee L V., Rivera C, Teleg R A. et al. The unique phenomenology of sex-linked dystonia parkinsonism (XDP, DYT3, Lubag). Int J Neurosci 2011 121 Suppl 1 3-11
52. Waters C H., Faust P L., Powers J et al. Neuropathology of lubag (x-linked dystonia parkinsonism). Mov Disord 1993 8 3 387-390 (Pubitemid 23212558)
53. Evidente V G., Advincula J, Esteban R et al. Phenomenology of Lubag or X-linked dystonia-parkinsonism. Mov Disord 2002 17 6 1271-1277
54. Goto S, Lee L V., Munoz E L. et al. Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism. Ann Neurol 2005 58 1 7-17 (Pubitemid 40962456)
55. Makino S, Kaji R, Ando S et al. Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet 2007 80 3 393-406
56. Segawa M. Dopa-responsive dystonia. Handb Clin Neurol 2011 100 539-557
57. Arrabal L, Teresa L, Sánchez-Alcudia R et al. Genotype-phenotype correlations in sepiapterin reductase deficiency. A splicing defect accounts for a new phenotypic variant. Neurogenetics 2011 12 3 183-191
58. Grötzsch H, Pizzolato G P., Ghika J et al. Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14. Neurology 2002 58 12 1839-1842 (Pubitemid 34663588)
59. Wider C, Melquist S, Hauf M et al. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5. Neurology 2008 70 16 Pt 2 1377-1383 (Pubitemid 351521928)
60. Brashear A, Dobyns W B., de Carvalho Aguiar P et al. The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. Brain 2007 130 Pt 3 828-835 (Pubitemid 46410729)
61. Blanco-Arias P, Einholm A P., Mamsa H et al. A C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism. Hum Mol Genet 2009 18 13 2370-2377
62. Einholm A P., Toustrup-Jensen M S., Holm R, Andersen J P., Vilsen B. The rapid-onset dystonia parkinsonism mutation D923N of the Na+, K+-ATPase alpha3 isoform disrupts Na+ interaction at the third Na+ site. J Biol Chem 2010 285 34 26245-26254
63. Rodacker V, Toustrup-Jensen M, Vilsen B. Mutations Phe785Leu and Thr618Met in Na+,K+-ATPase, associated with familial rapid-onset dystonia parkinsonism, interfere with Na+ interaction by distinct mechanisms. J Biol Chem 2006 281 27 18539-18548 (Pubitemid 44035513)
64. Kabakci K, Isbruch K, Schilling K et al. Genetic heterogeneity in rapid onset dystonia-parkinsonism: description of a new family. J Neurol Neurosurg Psychiatry 2005 76 6 860-862 (Pubitemid 40805819)
65. Camargos S, Scholz S, Simn-Sánchez J et al. DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol 2008 7 3 207-215
66. Seibler P, Djarmati A, Langpap B et al. A heterozygous frameshift mutation in PRKRA (DYT16) associated with generalised dystonia in a German patient. Lancet Neurol 2008 7 5 380-381 (Pubitemid 351508475)
67. Nardocci N. Myoclonus-dystonia syndrome. Handb Clin Neurol 2011 100 563-575
68. Kyllerman M, Forsgren L, Sanner G, Holmgren G, Wahlström J, Drugge U. Alcohol-responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation. Mov Disord 1990 5 4 270-279 (Pubitemid 20373606)
69. Peall K J., Waite A J., Blake D J., Owen M J., Morris H R. Psychiatric disorders, myoclonus dystonia, and the epsilon-sarcoglycan gene: A systematic review. Mov Disord 2011 Jun 28
70. Kinugawa K, Vidailhet M, Clot F, Apartis E, Grabli D, Roze E. Myoclonus-dystonia: an update. Mov Disord 2009 24 4 479-489
71. Asmus F, Hjermind L E., Dupont E et al. Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype. Brain 2007 130 Pt 10 2736-2745 (Pubitemid 47511717)
72. Bonnet C, Grgoire M J., Vibert M, Raffo E, Leheup B, Jonveaux P. Cryptic 7q21 and 9p23 deletions in a patient with apparently balanced de novo reciprocal translocation t(7;9)(q21;p23) associated with a dystonia-plus syndrome: paternal deletion of the epsilon-sarcoglycan (SGCE) gene. J Hum Genet 2008 53 10 876-885
73. Guettard E, Portnoi M F., Lohmann-Hedrich K et al. Myoclonus-dystonia due to maternal uniparental disomy. Arch Neurol 2008 65 10 1380-1385
74. Zimprich A, Grabowski M, Asmus F et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 2001 29 1 66-69 (Pubitemid 32801811)
75. Beukers R J., Foncke E M., van der Meer J N., Veltman D J., Tijssen M A. Functional magnetic resonance imaging evidence of incomplete maternal imprinting in myoclonus-dystonia. Arch Neurol 2011 68 6 802-805
76. Hack A A., Groh M E., McNally E M. Sarcoglycans in muscular dystrophy. Microsc Res Tech 2000 48 3-4 167-180 (Pubitemid 30086190)
77. Han F, Racacho L, Lang A E., Bulman D E., Grimes D A. Refinement of the DYT15 locus in myoclonus dystonia. Mov Disord 2007 22 6 888-892 (Pubitemid 46800118)
78. Grimes D A., Han F, Lang A E., St George-Hyssop P, Racacho L, Bulman D E. A novel locus for inherited myoclonus-dystonia on 18p11. Neurology 2002 59 8 1183-1186 (Pubitemid 35192387)
79. Bruno M K., Lee H Y., Auburger G W. et al. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology 2007 68 21 1782-1789 (Pubitemid 46791390)
80. Rainier S, Thomas D, Tokarz D et al. Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Arch Neurol 2004 61 7 1025-1029 (Pubitemid 38915943)
81. Lee H Y., Xu Y, Huang Y et al. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet 2004 13 24 3161-3170 (Pubitemid 40045268)
82. van Rootselaar A F., Schade van Westrum S, Velis D N., Tijssen M A. The paroxysmal dyskinesias. Pract Neurol 2009 9 2 102-109
83. Ghezzi D, Viscomi C, Ferlini A et al. Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence. Hum Mol Genet 2009 18 6 1058-1064
84. Spacey S D., Adams P J., Lam P C. et al. Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesia. Neurology 2006 66 10 1588-1590 (Pubitemid 43958565)
85. Mehta S H., Morgan J C., Sethi K D. Paroxysmal dyskinesias. Curr Treat Options Neurol 2009 11 3 170-178
86. Suls A, Dedeken P, Goffin K et al. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 2008 131 Pt 7 1831-1844 (Pubitemid 351957463)
87. Weber Y G., Storch A, Wuttke T V. et al. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 2008 118 6 2157-2168 (Pubitemid 351872334)
88. Schneider S A., Paisan-Ruiz C, Garcia-Gorostiaga I et al. GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias. Mov Disord 2009 24 11 1684-1688
89. Roubergue A, Apartis E, Mesnage V et al. Dystonic tremor caused by mutation of the glucose transporter gene GLUT1. J Inherit Metab Dis 2011 34 2 483-488
90. Weber Y G., Kamm C, Suls A et al. Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology 2011 77 10 959-964
91. Ku C S., Naidoo N, Pawitan Y. Revisiting Mendelian disorders through exome sequencing. Hum Genet 2011 129 4 351-370